RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Wirano (the platform for clinical trials)

Product
Developers: PF Rus
Date of the premiere of the system: October, 2020
Branches: Pharmaceutics, medicine, health care

2020: Wirano start - platforms for clinical trials

In October, 2020 it became known of start of the platform for the organization of clinical trials worldwide. It is about the digital solution Wirano which is developed by PF Rus company (the resident Skolkovo).

According to developers, Wirano will allow to communicate effectively among themselves to all participants of process: to pharmaceutical companies, doctors-researchers and patients. Producers of medicines will be able quickly to pick up research commands in the different countries, doctors – quickly to place information on clinical trial for patients and to begin set, and patients – to find suitable clinical trial and to submit the application for participation in it.

In Russia the platform for the organization of clinical trials appeared worldwide
File:Aquote1.png
Extremely important planning process and start of clinical trials is far from perfect. So, from start of a research before inclusion of the first patient on average there pass 6-10 months. A half of the planned clinical trials do not achieve effective objectives on set of patients in the stated terms. Taking into account that the cost of one day of a delay can reach $1 million, pharmaceutical companies incur huge expenses that affects afterwards availability and cost of medicines — one of co-founders of Wirano Andrey Tarakanov told.
File:Aquote2.png

Over the Wirano project within a year the command works with more than 20 years' experience in area of clinical trials. Including founders of the project participated in creation of a number of the international projects, including the contract research organization (CRO) of Cromos Pharma and the company on logistics of clinical trials of COREX Logistics which are one of leaders in the market of the CIS and Eastern Europe.

By October, 2020 the module is developed for patients whose set will begin until the end of 2020. In 2021 connection of the first sponsors and the research centers is planned. The next step – scaling and an exit to global markets. The existing representative office of Wirano in Ireland will be connected to this process.[1]

Notes